Tremelimumab 300mg/15ml solution for infusion vials
- SNOMED code
42237711000001100- Active compound
- Tremelimumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 15 ml, vial
- Ingredients
- Tremelimumab
— 20 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Imjudo 300mg/15ml concentrate for solution for infusion vials (AstraZeneca UK Ltd)
in short Imjudo 300mg/15ml concentrate for inf vials
Imjudo 300mg/15ml concentrate for solution for infusion vials
- SNOMED code
42173311000001106- Supplier
- AstraZeneca UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Imjudo 300mg/15ml concentrate for solution for infusion vials (AstraZeneca UK Ltd) 1 vial42173411000001104 ref. pack | 💯 Available Legal category: POM | 500045603721105000456037211 | NHS Indicative Price £20,610 | • Hospital |
| — |
Reference packs
Tremelimumab 300mg/15ml solution for infusion vials 1 vial
- SNOMED code
42173211000001103- Quantity and unit
- 1 vial
- Packs